Navigation Links
EXTENDED HEALTH: Noverca Enters the World of Healthcare
Date:4/8/2011

ROME, April 8, 2011 /PRNewswire/ -- Noverca – the first and currently only Italian 'Full MVNO' – has expanded its product offerings by announcing its presence in the Health and Wellness Sector.

An innovative telematic support model to support diabetes treatment has been developed and launched thanks to the long-term partnership between Acotel Group (Parent company of Noverca) and Fatebenefratelli Hospital. Davide Carnevale, Marketing & Sales Director at Noverca Italia, made the announcement during an Italy Expo Comm Italia 2011 press conference.

The telematic support product ensures a constant monitoring solution which enables patients to access their own health activity data on multiple channels including SMS, web, and Smartphone applications, and allows them to share the data with others, including doctors and family, resulting in heightened awareness and overall superior care."The partnership with Fatebenefratelli and the monitoring of diabetic patients is only the first step into the world of Healthcare," said Davide Carnevale.  "Moreover, we are ready to cover many other aspects of the Health and Wellness field."

At the heart of the Noverca system is the patent pending MiniMAU (Management Automation Unit) with embedded SIM Noverca 2.0.  The MiniMAU operates as a patient data access point to the GSM network and interfaces, via either IrDA, Bluetooth, or USB, with medical devices used by patients (e.g. glucometers) while communicating with the central platform.

The platform processes data relating to medical indicators of the patient and provides a full range of analyses useful for diagnostic and management purposes.  If requested, the platform will automatically send alerts via SMS and/or email, thereby permitting healthcare professionals to intervene and modify treatment in real time.

"In addition to our numerous mobile phone services," Davide Carnevale continues, "We will shortly be launching additional 2.0 services in the Health & Wellness, Security and Energy Control management sectors, as well as introducing a new and important concept of social networking."

About Acotel Group: Acotel Group, parent company to Flycell, JinnySoftware, Info2cell, & Noverca Italia, is a global provider of multimedia platforms and applications to mobile network operators and media companies around the world.  Through its customer base, Acotel services more than 35 million end users, and enabled 340 million paid text and multimedia messages in 2002.  Founded in 1992, Acotel operates in 20 countries and is publicly traded on the Milan Stock Exchange.Press OfficePress OfficeCast Adv. & CommunicationCommunication Area - Noverca Italiapressoffice@castadv.it

Alessandro MasciarelliTel.+ 39 06.33252983

alessandro.masciarelli@noverca.itAdriano Conti, Daniela Primerano, Stefania Caucci

Tel. + 39 06.61143000Who is Noverca Italia: Noverca Italia (www.noverca.it) is a company born out of the industrial cooperation starting in 2008 between the Acotel Group and the banking Group Intesa Sanpaolo.  The company is one of the main Italian virtual mobile operators and has always been distinguished by its ability to introduce services with high added value onto the market.


'/>"/>
SOURCE Noverca Italia
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Tris Announces NDA Acceptance of Extended Release Carbinoxamine Oral Suspension for the Treatment of Allergies in Kids Two Years and Older
2. FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents
3. Mylan Receives Approval for First-to-File Generic Sular® Extended-Release Tablets
4. New Study Shows Tapentadol Extended Release (ER) May Significantly Reduce Average Pain Intensity for Diabetic Patients Suffering From Painful Peripheral Neuropathy
5. Shionogi Inc. Announces Commercial Availability of KAPVAY™ (clonidine hydrochloride) Extended-Release Tablets for the Treatment of ADHD
6. Data Suggests Positive Pharmacokinetic Results From Phase I Research of Extended-Release Topiramate
7. Upsher-Smith Laboratories Announces Initiation of Open-Label Extension Study of USL255 (Extended-Release Topiramate) for Adjunctive Treatment of Partial-Onset Epilepsy
8. Actavis Receives Approval of Zolpidem Tartrate Extended-Release Tablets, USP 6.25mg CIV in the U.S. with 180-Day Marketing Exclusivity
9. RoundTable Healthcare Partners Portfolio Company, Argon Medical Devices, Inc., Acquires Critical Care and Extended Dwell Catheter Product Platforms From BD
10. Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain
11. Abbotts SIMCOR ® ( niacin extended-release / simvastatin ) Receives FDA Approval for New Dosage Strengths
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... 2016  HemaFlo Therapeutics, Inc. announced today that the United ... Number 9,119,880 covering the use of NephroFlow to treat acute ... HemaFlo,s founder, said, "We are pleased to secure our rights ... Peterson , PhD, HemaFlo,s founder, said, "We are pleased to ... --> Dale Peterson , PhD, HemaFlo,s founder, said, ...
(Date:2/8/2016)... , Feb. 8, 2016  Sangamo BioSciences, Inc. ... genome editing, announced that the U.S. Food and ... New Drug (IND) application for SB-318, a single ... for Mucopolysaccharidosis Type I (MPS I). The SB-318 ... to initiate a Phase 1/2 clinical study (SB-318-1502) ...
(Date:2/8/2016)... , 8. Februar 2016  LivaNova, ... heute eine Infografik mit dem Titel „Epilepsy ... Welt), mit der der Krankheit gegenüber ein ... dazu ermutigen soll, Medikamentenresistenz bei Epilepsie auf ... allgemeinen Diskussion zu machen. Mithilfe der neuen ...
Breaking Medicine Technology:
(Date:2/8/2016)... Indianapolis, IN (PRWEB) , ... February 08, 2016 ... ... serving the Indianapolis, IN metro area, has selected the latest beneficiary of their ... nonprofit organization dedicated to preventing bullying in area schools. Donations are now being ...
(Date:2/8/2016)... San Francisco, CA (PRWEB) , ... February 08, 2016 , ... ... helped raise $792,000 to help combat pancreatic cancer. , Gary D. Radine, who recently ... who also was the American Cancer Society’s 2015 CEO of the Year , ...
(Date:2/8/2016)... ... February 08, 2016 , ... Remember the old saying “rub some ... to Perry A~, author of “Calcium Bentonite Clay” the health benefits of integrating clay ... and detoxifying the body. , A former motivational speaker, Perry A~ has since dedicated ...
(Date:2/8/2016)... ... February 08, 2016 , ... FileHold's document management ... DocuSyst provides a cloud hosted environment for FileHold software that is pay per ... 3rd party applications using the FileHold web services API. DocuSyst also advises clients ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... greater than 50% lower incidence rate of type 2 diabetes in the GrassrootsHealth ... ”It is time to make a change in public health,” states Carole Baggerly, ...
Breaking Medicine News(10 mins):